Increased oxidative stress in patients with congestive heart failure

Journal of the American College of Cardiology

Volumn 31, Issue 6, 1998, Pages 1352-1356

  Keith, Mary ^a,b   Geranmayegan, Amir ^a,b   Sole, Michael J ^a,b,d   Kurian, Regina ^a,b   Robinson, Andrew ^a,b   Omran, Ahmad S ^a,b   Jeejeebhoy, Khursheed N ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LIPID PEROXIDE; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS;

AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE PEROXIDASE; HEART FAILURE, CONGESTIVE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0032080550     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00101-6     Document Type: Article

References (38)

1. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22 Suppl A:6A-13A.
2. The SOLVD Investigators. The effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
3. Gupta M, Singal PK. Time course of structure, function and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol 1989;67:1549-59.
4. Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 1996;28:375-85.
5. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 1984;311: 819-23.
6. Daly P, Sole MJ. Myocardial catecholamines and the pathophysiology of heart failure. Circulation 1990;82:35-43.
7. Sole MJ, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 1993;22 Suppl A:99A-105A.
8. Factor SM, Minase T, Cho S, Dominita R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 1982;66:342-5.
9. Levine B, Kalman J, Mager L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
10. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995;92:1487-93.
11. Bobba A, Giannattasio S, Pucci A, Lippolis R, Camaschella C, Marra E. Characterization of mitochondrial DNA in primary cardiomyopathies. Clin Chim Acta 1995;243:181-9.
12. Singal BK, Beamish RE, Dhalla NS. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1983;161:391-401.
13. O'Donnell VB, Spycher S, Azzi A. Involvement of oxidants and oxidantgenerating enzyme(s) in tumour necrosis factor-α-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem J 1995;310:133-41.
14. Cortopassi G, Wang E. Modelling the effects of age-related mtDNA mutation accumulation: complex I deficiency, superoxide and cell death. Biochim Biophys Acta 1995;1271:171-6.
15. Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic Biol Med 1993;14:643-7.
16. McMurray J, McLay J, Chopra M, Bridges A, Bewlch JJF. Evidence for free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;65:1261-2.
17. Daiz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1966;131:146-52.
18. Ohishi N, Ohkawa H, Mike A, Tatano T, Yagi K. A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int 1985;10:205-11.
19. Tateishi T, Yoshimine N, Kuzuva F. Serum lipid peroxide assayed by a new colorimetric method. Exp Gerontol 1987;22:103-11.
20. Draper HH. Malondialdehyde determination. Methods Enzymol 1990;186: 421-31.
21. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 1993;15:353-63.
22. Bieri JG, Tolliver TJ, Catignani CL. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by HPLC. Am J Clin Nutr 1979;32:3143-9.
23. Peters SA, Kelly FJ. Vitamin E supplementation in cystic fibrosis. J Pediatr Gastroenterol Nutr 1996;22:341-5.
24. Lehman J. Comparative sensitivities of tocopherol levels of platelets, red blood cells and plasma for estimating vitamin E nutritional status in the rat. Am J Clin Nutr 1981;34:2104-10.
25. Paglia DC, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
26. McGee CD, Ostro MJ, Kurian R, Jeejeebhoy KN. Vitamin E and selenium status of patients receiving short-term total parenteral nutrition. Am J Clin Nutr 1985;42:432-8.
27. Laboratory procedure of the Clinical Chemistry Division, Centers for Disease Control, for the Second Health and Nutrition Examination (NHANES II) 1976-1980, U.S. Department of Health and Human Services, Public Health Services IV-Analytical Methods, Vit C, pp 17-19, Atlanta, Georgia.
28. Kaul N, Siveski-iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods 1993;30:55-67.
29. Packer JE, Slater TF, Wilson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-8.
30. Singh N, Dhalla AK, Seneviratne C, Singal PK. Oxidative stress and heart failure. Mol Cell Biochem 1995;147:77-81.
31. Li R-K, Sole MJ, Mickle DAG, Schimmer J, Goldstein D. Vitamin E and oxidative stress in the heart of the cardiomyopathic Syrian hamster. Free Radic Biol Med 1998;24:252-8.
32. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster. J Am Coll Cardiol 1987;10:1128-34.
33. Jamall IS, Haldar D, Wadewitz AG. Effects of dietary selenium on lipid peroxidation, mitochondrial function and protein profiles in the heart of the cardiomyopathic Syrian Golden hamster (Bio 14.6). Biochem Biophys Res Commun 1987;144:815-20.
34. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994;121:860-2.
35. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-86.
36. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro. Am J Physiol 1995;37:H517-23.
37. Hoshino E, Shariff R, Van Gossum A, et al. Vitamin E suppresses increased lipid peroxidation in cigarette smokers. J Parenterel Enteral Nutr 1990;14: 300-5.
38. Van Gossum A, Shariff R, Lemoyne M, Kurian R, Jeejeebhoy K. Increased lipid peroxidation after lipid infusion as measured by breath pentane output. Am J Clin Nutr 1988;48:1394-9.